| Shinmori Optometry | |
|
214 Jackson St, San Jose, CA 95112-3201 | |
| (408) 293-3730 | |
| (408) 293-2131 |
| Full Name | Shinmori Optometry |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 214 Jackson St, San Jose, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013985266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | COR 1134 (California) | Primary |
| Provider Name | Tina C Shinmori |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376610592 PECOS PAC ID: 5092753236 Enrollment ID: I20050419001081 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
| Provider Name | Esther O Kim |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1780709329 PECOS PAC ID: 8325054836 Enrollment ID: I20060221000574 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
| Provider Name | Tera R Nakano |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1528134624 PECOS PAC ID: 7618987694 Enrollment ID: I20060504000850 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
| Provider Name | Hoa Tat |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366411837 PECOS PAC ID: 6305943986 Enrollment ID: I20070515000618 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
| Provider Name | Kristen Ying Oda |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174048698 PECOS PAC ID: 5395018568 Enrollment ID: I20170911000481 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shinmori Optometry 214 Jackson St, San Jose, CA 95112-3201 Ph: (408) 293-3730 | Shinmori Optometry 214 Jackson St, San Jose, CA 95112-3201 Ph: (408) 293-3730 |
News Archive
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
The Beryl Institute released a report highlighting results from its recent patient experience benchmarking study conducted in collaboration with Catalyst Healthcare Research, an independent marketing research firm.
› Verified 9 days ago
Cyndi C Lee, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1558 S Bascom Ave, San Jose, CA 95125 Phone: 408-371-5180 | |
Christopher Ngo, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1080 S White Rd, A, San Jose, CA 95127 Phone: 408-272-3002 | |
Kari Tran, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2380 Montpelier Dr, Ste 300, San Jose, CA 95116 Phone: 408-272-3706 Fax: 408-254-4094 | |
Dr. Duc Minh Bui, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4095 Evergreen Village Sq Ste 110, San Jose, CA 95135 Phone: 408-532-1308 | |
Ms. Cecilia K Imamura, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 55 E Julian St, San Jose, CA 95112 Phone: 408-918-2618 Fax: 408-795-1129 | |
Shirley Quicho, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 590 Blossom Hill Rd, San Jose, CA 95123 Phone: 408-227-2020 Fax: 206-338-0411 |